Perspix Biotech

Curated by Signal

Developer of biotherapeutics for the treatment of cancer

Overview

Developer of biotherapeutics for the treatment of cancer. The company has AI-driven protein engineering and a Perspix platform for the development and optimization of novel biomolecular drug candidates for cancer treatment.

Key facts

Founded: 2021
Headquarters: Frankfurt Am Main, Germany
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

DyNAbind
Developer of DNA-Encoded Library drug discovery
Life Sciences TechnologyDresden, Germany
Decodon
Tools for Functional Genomics
Life Sciences TechnologyGreifswald, Germany
Ribocon
Provider of software for identification of microbes based on ribosomal RNA gene sequences
Life Sciences TechnologyBremen, Germany

About Perspix Biotech

What does Perspix Biotech do?

Developer of biotherapeutics for the treatment of cancer.

Where is Perspix Biotech headquartered?

Perspix Biotech is headquartered in Frankfurt Am Main, Germany.

When was Perspix Biotech founded?

Perspix Biotech was founded in 2021.

Which sector is Perspix Biotech in?

Perspix Biotech operates in Life Sciences Technology.

Who are Perspix Biotech's competitors?

Companies similar to Perspix Biotech include DyNAbind, Decodon, and Ribocon.